ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,816Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 113

$490K Total Retail Price of All Prescriptions

Rank: 32 out of 113

297 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 297 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 297 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,413 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 403 323 1 1
SIMVASTATIN 388 336 2 2
LISINOPRIL 335 269 3 3
FUROSEMIDE 304 264 4 6
OMEPRAZOLE 303 274 5 5
POTASSIUM CHLORIDE 289 266 6 12
WARFARIN SODIUM 202 194 7 8
LOSARTAN POTASSIUM 199 188 8 13
SERTRALINE HCL 186 158 9 21
CITALOPRAM HBR 185 174 10 17
METFORMIN HCL 164 141 11 11
AMLODIPINE BESYLATE 161 133 12 4
HYDROCODONE-ACETAMINOPHEN 154 122 S3 13 7
FLUTICASONE PROPIONATE 124 109 14 39
METOPROLOL SUCCINATE 122 119 15 10
METOPROLOL TARTRATE 118 101 16 14
ZOLPIDEM TARTRATE 114 80 17 19
TRIAMTERENE-HCTZ 111 86 18 26
RANITIDINE HCL 111 87 18 96
PREDNISONE 110 99 20 28
ALENDRONATE SODIUM 108 96 21 22
ATORVASTATIN CALCIUM 104 102 22 15
GABAPENTIN 99 69 23 18
DIGOXIN 98 90 24 27
DONEPEZIL HCL 98 98 24 33
LEVOFLOXACIN 93 85 26 139
JANUVIA 85 72 27 85
HYDROCHLOROTHIAZIDE 84 78 28 9
CYMBALTA 79 47 29 37
NAMENDA 78 78 30 48
PANTOPRAZOLE SODIUM 77 73 31 52
ATENOLOL 76 67 32 16
CARVEDILOL 76 61 32 25
CRESTOR 73 51 34 30
PRAVASTATIN SODIUM 69 69 35 23
TRAMADOL HCL 66 40 36 29
AZITHROMYCIN 63 48 37 65
ROPINIROLE HCL 61 44 38 67
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 39 40
KLOR-CON 8 54 54 40 193
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.